Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2019

Ausgabe 3/2019

Inhaltsverzeichnis ( 26 Artikel )

03.07.2019 | Review | Ausgabe 3/2019

Social determinants of breast cancer risk, stage, and survival

Steven S. Coughlin

04.07.2019 | Review | Ausgabe 3/2019

Treating HR+/HER2− breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression

Winnie Yeo, Takayuki Ueno, Ching-Hung Lin, Qiang Liu, Kyung-Hun Lee, Roland Leung, Yoichi Naito, Yeon Hee Park, Seock-Ah Im, Huiping Li, Yoon Sim Yap, Yen-Shen Lu, The Asian Breast Cancer Cooperative Group

10.07.2019 | Review | Ausgabe 3/2019

Awareness of residents’ technical ability can affect margin status in breast conserving operations

Joel VanderVelde, Jarvis W. Walters, Chiu-Hsieh Hsu, Elizabeth M. N. Ferguson, Jennifer Lee, Daniel M. Caruso, Ian K. Komenaka

11.07.2019 | Review | Ausgabe 3/2019

Muscle composition and outcomes in patients with breast cancer: meta-analysis and systematic review

G. F. P. Aleixo, G. R. Williams, K. A. Nyrop, H. B. Muss, S. S. Shachar

02.07.2019 | Preclinical study | Ausgabe 3/2019

Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer

Jasmin Zeindler, Fiorenzo Angehrn, Raoul Droeser, Silvio Däster, Salvatore Piscuoglio, Charlotte K. Y. Ng, Ergin Kilic, Robert Mechera, Samuel Meili, Andrej Isaak, Walter P. Weber, Simone Muenst, Savas Deniz Soysal

08.07.2019 | Preclinical study | Ausgabe 3/2019

Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination

Takeshi Murata, Takako Yanagisawa, Toshiaki Kurihara, Miku Kaneko, Sana Ota, Ayame Enomoto, Masaru Tomita, Masahiro Sugimoto, Makoto Sunamura, Tetsu Hayashida, Yuko Kitagawa, Hiromitsu Jinno

09.07.2019 | Preclinical study | Ausgabe 3/2019

β2-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer

Sasagu Kurozumi, Kyoichi Kaira, Hiroshi Matsumoto, Tomoko Hirakata, Takehiko Yokobori, Kenichi Inoue, Jun Horiguchi, Ayaka Katayama, Hiromi Koshi, Akira Shimizu, Tetsunari Oyama, Erica K. Sloan, Masafumi Kurosumi, Takaaki Fujii, Ken Shirabe

13.07.2019 | Preclinical study | Ausgabe 3/2019

Genomic comparison of paired primary breast carcinomas and lymph node macrometastases using the Oncotype DX Breast Recurrence Score® test

Susan K. Boolbol, Manju Harshan, Manjeet Chadha, Laurie Kirstein, Jean-Marc Cohen, Paula Klein, Joseph Anderson, Deborah Davison, Debbie M. Jakubowski, Frederick L. Baehner, Stephen Malamud

15.07.2019 | Preclinical study | Ausgabe 3/2019

Breast pain and cancer: should we continue to work-up isolated breast pain?

Marina Mohallem Fonseca, Leslie R. Lamb, Raman Verma, Olaitan Ogunkinle, Jean M. Seely

19.07.2019 | Preclinical study | Ausgabe 3/2019

Non-contrast MRI for breast screening: preliminary study on detectability of benign and malignant lesions in women with dense breasts

Yangyang Bu, Jun Xia, Bobby Joseph, Xianjing Zhao, Maosheng Xu, Yingxing Yu, Shouliang Qi, Kamran A. Shah, Shiwei Wang, Jiani Hu

14.06.2019 | Clinical trial | Ausgabe 3/2019 Open Access

Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians

L. Fallowfield, I. Solis-Trapala, R. Starkings, S. Catt, S. May, V. Jenkins

02.07.2019 | Clinical trial | Ausgabe 3/2019

The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer

Shinsuke Sasada, Noriyuki Shiroma, Noriko Goda, Keiko Kajitani, Akiko Emi, Norio Masumoto, Takayuki Kadoya, Koji Arihiro, Morihito Okada

11.07.2019 | Clinical trial | Ausgabe 3/2019

PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

William Jacot, Florence Dalenc, Evelyne Lopez-Crapez, Leonor Chaltiel, Anna Durigova, Nathalie Gros, Nicolas Lozano, Jean-Louis Lacaze, Stéphane Pouderoux, Laurence Gladieff, Gilles Romieu, Henri Roché, Thomas Filleron, Pierre-Jean Lamy

16.07.2019 | Clinical trial | Ausgabe 3/2019

The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry

Sang eun Nam, Woosung Lim, Joon Jeong, Seeyoun Lee, Jungeun Choi, HeungKyu Park, Yong Sik Jung, Seung Pil Jung, Soo Youn Bae

01.07.2019 | Epidemiology | Ausgabe 3/2019

Mode of detection and breast cancer mortality by follow-up time and tumor characteristics among screened women in Cancer Prevention Study-II

Samantha Puvanesarajah, Susan M. Gapstur, Alpa V. Patel, Mark E. Sherman, W. Dana Flanders, Ted Gansler, Melissa A. Troester, Mia M. Gaudet

01.07.2019 | Epidemiology | Ausgabe 3/2019 Open Access

A generalizable relationship between mortality and time-to-death among breast cancer patients can be explained by tumour dormancy

Vasily Giannakeas, Steven A. Narod

06.07.2019 | Epidemiology | Ausgabe 3/2019

Mammographic screening in male patients at high risk for breast cancer: is it worth it?

Maria Adele Marino, Ayca Gucalp, Doris Leithner, Delia Keating, Daly Avendano, Blanca Bernard-Davila, Elizabeth A. Morris, Katja Pinker, Maxine S. Jochelson

11.07.2019 | Epidemiology | Ausgabe 3/2019

Quantifying the relationship between age at diagnosis and breast cancer-specific mortality

Helen M. Johnson, William Irish, Mahvish Muzaffar, Nasreen A. Vohra, Jan H. Wong

13.07.2019 | Epidemiology | Ausgabe 3/2019 Open Access

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Bernadette A. M. Heemskerk-Gerritsen, Agnes Jager, Linetta B. Koppert, A. Inge-Marie Obdeijn, Margriet Collée, Hanne E. J. Meijers-Heijboer, Denise J. Jenner, Hester S. A. Oldenburg, Klaartje van Engelen, Jakob de Vries, Christi J. van Asperen, Peter Devilee, Marinus J. Blok, C. Marleen Kets, Margreet G. E. M. Ausems, Caroline Seynaeve, Matti A. Rookus, Maartje J. Hooning

13.07.2019 | Epidemiology | Ausgabe 3/2019

Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions

Caroline McGugin, Tara Spivey, Suzanne Coopey, Barbara Smith, Bridget Kelly, Michele Gadd, Kevin Hughes, Brian Dontchos, Michelle Specht

17.07.2019 | Epidemiology | Ausgabe 3/2019

Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties

Rong Tang, Francisco Acevedo, Conor Lanahan, Suzanne B. Coopey, Adam Yala, Regina Barzilay, Clara Li, Amy Colwell, Anthony J. Guidi, Curtis Cetrulo, Judy Garber, Barbara L. Smith, Michele A. Gadd, Michelle C. Specht, Kevin S. Hughes

17.07.2019 | Epidemiology | Ausgabe 3/2019

Domain-specific patterns of physical activity and risk of breast cancer sub-types in the MCC-Spain study

José M. Huerta, Antonio J. Molina, María Dolores Chirlaque, Pedro Yepes, Ferrán Moratalla-Navarro, Víctor Moreno, Pilar Amiano, Marcela Guevara, Conchi Moreno-Iribas, Javier Llorca, Guillermo Fernández-Tardón, Ana Molina-Barceló, Juan Alguacil, Rafael Marcos-Gragera, Gemma Castaño-Vinyals, Beatriz Pérez-Gómez, Manolis Kogevinas, Marina Pollán, Vicente Martín

28.06.2019 | Brief Report | Ausgabe 3/2019

Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study

Antonio Ponti, Guglielmo Ronco, Elsebeth Lynge, Mariano Tomatis, Ahti Anttila, Nieves Ascunce, Mireille Broeders, Jean-Luc Bulliard, Isabella Castellano, Patricia Fitzpatrick, Alfonso Frigerio, Solveig Hofvind, Ondřej Májek, Nereo Segnan, Stephen Taplin, the ICSN DCIS Working Group

10.07.2019 | Brief Report | Ausgabe 3/2019

Double heterozygous mutation in the BRCA1 and ATM genes involved in development of primary metachronous tumours: a case report

Raquel Andrés, Sebastian Menao, María Arruebo, Elisa Quílez, Maria José Cardiel

04.07.2019 | Letter to the Editor | Ausgabe 3/2019

RE.: Impact of long-term lipid-lowering therapy on clinical outcomes in breast cancer

Sixten Harborg, Deirdre P. Cronin-Fenton, Signe Borgquist

12.07.2019 | Correction | Ausgabe 3/2019

Correction to: Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer

Edoardo Isnaldi, Domenico Ferraioli, Lorenzo Ferrando, Sylvain Brohée, Fabio Ferrando, Piero Fregatti, Davide Bedognetti, Alberto Ballestrero, Gabriele Zoppoli

Aktuelle Ausgaben